Medibank share price drops after results — dividend lift, premium hike and what investors watch next
19 February 2026

Medibank share price drops after results — dividend lift, premium hike and what investors watch next

Sydney, Feb 19, 2026, 18:13 (AEDT) — After-hours

  • Medibank ended the day off 6.2% following its half-year results release.
  • The interim dividend’s up 6.4%, now at 8.3 Australian cents per share, fully franked.
  • Premiums climbed in April, putting a spotlight back on member growth and claims expenses.

Shares of Medibank Private Ltd dropped 6.2% on Thursday, closing at A$4.50. The insurer surrendered some of the previous session’s gains as investors digested its half-year results.

Medibank reported that underlying net profit after tax, which excludes investment market swings, edged down 0.3% to A$297.8 million for the six months to Dec. 31. The board, though, bumped up the interim dividend by 6.4% to 8.3 Australian cents per share, fully franked—so it comes with local tax credits. “We’ve delivered on our growth commitments,” Chief Executive David Koczkar said, highlighting stronger momentum in health insurance and the expansion of the group’s health services business.

The numbers drop just as health insurers brace for April’s price reset, after Canberra approved an average 4.41% hike in private health insurance premiums starting April 1. The government also plans to ban “product phoenixing”—a tactic where insurers shutter a product only to relaunch a near-duplicate at a steeper price. Health, Disability and Ageing

Medibank will lift its premiums by an average of 5.10% starting April 1, following the green light from the government. That’s higher than the industry average.

Medibank’s investor presentation showed group operating profit climbing 6% to A$381.7 million. Health Insurance operating profit edged up 3.5% to A$361.5 million; profits in the Medibank Health segment jumped 28.5% to A$48.3 million. Net resident policyholder numbers increased by 38,300 over the year. The company also highlighted its acquisition of Better Medical for A$163.5 million, signaling a deeper move into primary care.

Top-line gains didn’t filter through everywhere. Net investment income slid 17.1% to A$94.9 million. Medibank also pointed to A$15.0 million in one-off cybercrime expenses linked to the 2022 breach—covering security upgrades plus legal and regulatory costs.

That marked a shift from Wednesday. Back then, Australian media had reported gains for health insurers like Medibank and NIB Holdings following the premium approvals.

NIB plans to hike its health insurance premiums by an average of 5.47% starting April 1.

Medibank’s underlying net profit for the first half landed at roughly A$298 million, coming in 2% to 4% shy of forecasts, according to Citi’s Nigel Pittaway. He pointed to softer returns from the private health insurance division and rising expenses.

There’s a risk here: larger premium hikes could draw fresh attention to value for money, nudging cost-conscious customers to switch plans or exit entirely, even as hospital and medical expenses keep rising. Throw in any additional cyber charges or negative regulatory news, and that would drag on sentiment, too.

Now attention turns to broker updates and potential tweaks to FY26 forecasts before Medibank’s interim dividend dates come up. Shares go ex-dividend Feb. 26, with the payout scheduled for March 18.

Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap

NYSE: AER 95 / 100
#2 BUY

Constellation Energy

NASDAQ: CEG 94 / 100
#3 BUY ON PULLBACK

Cheniere Energy

NYSE: LNG 92 / 100
#4 BUY

Walt Disney

NYSE: DIS 90 / 100
#5 ACCUMULATE

AIG

NYSE: AIG 88 / 100
View full portfolio
Editorial model selection. Not personalised advice.
HUB24 share price surges 14% after half-year profit jump and FY27 target upgrade
Previous Story

HUB24 share price surges 14% after half-year profit jump and FY27 target upgrade

Pro Medicus share price rebounds 5% as ASX:PME steadies after selloff — what to watch next week
Next Story

Pro Medicus share price rebounds 5% as ASX:PME steadies after selloff — what to watch next week